Nucleoside/nucleotide analog consolidation therapy in hepatitis B e-antigen positive chronic hepatitis B patients: Three years should be preferred-MedSci.cn

Nucleoside/nucleotide analog consolidation therapy in hepatitis B e-antigen positive chronic hepatitis B patients: Three years should be preferred

Li, T; Liang, Y; Zhang, M; Liu, F; Zhang, LX; Yang, BH; Wang, L

Yang, BH; Wang, L (corresponding author), Shandong Univ, Second Hosp, Dept Infect Dis & Hepatol, Cheeloo Coll Med, 247 Beiyuan Rd, Jinan, Peoples R China.

HEPATOLOGY RESEARCH, 2021; 51 (6): 633

Abstract

Aim To assess the role of consolidation therapy after cessation of nucleoside/nucleotide analogs (NAs) for off-treatment outcome and to explore the op......

Full Text Link